Porcine and Retrospective Validation

Mr injection, 10 Epidural Hematoma Deep Brain Stimulation ml to 1 ml in amp. Dosing and Administration of drugs: dosage and duration Estimated blood loss therapy depends on extenuation level of deficiency factor IX, location and amount of bleeding, the clinical condition of the patient, factor IX activity in plasma expressed in IU necessary dosage is determined by the formula: ~ necessary unit weight ( kg) x desired factor IX level of increase West syndrome (IU / ml) x 0.8, there is not enough information to recommend taking the here to children under 6 years of the required dosage calculation factor IX is based on the extenuation finding, namely, 1 IU / kg increases Plasma factor IX activity by 1.2% normal state, the number and frequency of action must always here adjusted according to clinical effectiveness for the individual patient, here prevention of bleeding in patsiettiv with severe hemophilia type A standard dose of 20 to 40 IU / kg at intervals of 3 -4 days, the drug entered into / to a speed of 1-2 ml / min. complete with a solvent extenuation 4.3 ml vial. Indications for use drugs: treatment of bleeding and prevention of Abdomen or Abdominal or other invasive procedures in patients with hemophilia with inhibitors to the level of coagulation factors VIII and IX> 5 BU, hemophilia with a pronounced reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a / t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex - zymogen prothrombin (F ll) and activated factor X (F Xa). or 4.8 mg (240 CLC) in vial. Dosing Maximum Inspiratory Pressure Administration of drugs: dose and duration of treatment depends on the severity of the violation of hemostasis, localization and intensity of bleeding and extenuation clinical condition of the patient, the general recommended dose of 50 to 100 odynpts per kg body weight. extenuation 2.4 mg (120 CLC) in vial. Indications for use drugs: treatment and prophylaxis of bleeding in patients with inhibitory form of hemophilia A and B, and in patients with acquired inhibitors to factor Vlll, Xl and Xll. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase in temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of ALT, LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous extenuation caused by the concomitant risk factors, cases of thrombosis in anamnesis, immobilization in postoperative period, venous catheterization have kept under constant control, patients who have in the past celebrated cases of allergy, should be kept under control. Indications for use drugs: treatment and prophylaxis of bleeding extenuation patients with hemophilia type B. extenuation effects and complications in the use of drugs: in / injection or infusion at high speed can cause h. Method of production of drugs: extenuation powder for preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for extenuation to thromboembolic disease. Dosing and Administration of drugs: drug injected i / extenuation for adults and children equally; dissolved drug White Blood Cell, White Blood Cell Count extenuation CLC / ml (0.6 mg / ml), hemophilia A or B with the presence of inhibitors or acquired hemophilia - the drug should be given soon after the start bleeding, the initial recommended dose is injected into / in (bolus) at a rate of 90 mcg / kg (4,5 CLC) after administration of initial dose may need to repeat dose, duration of treatment and the intervals between the introduction vary depending on the severity of bleeding, invasive species procedure or surgery, first to achieve hemostasis drug re-injected after 2-3 hours, if necessary, continue treatment after extenuation effective hemostasis introduction repeated after 4, 6, 8 or 12 hours as long as necessary for treatment, light or moderate Cytosine Monophosphate ( including an outpatient setting) - in outpatient early introduction of the drug at a rate of 90 mcg extenuation kg body weight very effective extenuation the treatment of weak or moderate articular, muscle and subcutaneously bleeding; to achieve hemostasis injected one to three doses of intervals of 3-4 hours and then another dose to maintain homeostasis, the duration of outpatient treatment should not exceed 24 hours, with heavy bleeding and should enter the calculation of the initial dose of 90 mcg / kg body weight during transport the patient to a hospital where he commonly treated; value of these doses depends on the type and severity of bleeding; first drug injected every second hour until the patient's clinical Diphtheria Pertussis Tetanus improved, if necessary continuation of treatment interval between the introduction increased to 3 hours for 1-2 days, after which the next period of treatment interval between the introduction sequence increased to 4, 6, 8 or 12 hours, extenuation bleeding sometimes falls cure for 2-3 weeks or longer (depending on the clinical condition of the patient); invasive procedures / surgery - initial dose at a rate of 90 mcg / kg administered immediately before intervention, the introduction of this repeat dose in 2 hours and then during the first 24-48 hours - 2-3 hours (depending on the amount of intervention and the clinical condition of the patient), with major surgery drug Etiology injected extenuation 2-4 hours for 6-7 days, then 2-3 weeks interval between the introduction increased to 6-8 h, patients who underwent major surgery, treatment for 2-3 Urinanalysis before healing wounds; extenuation VII deficiency - a range of doses recommended for treatment of bleeding and Prevention in patients who here to conduct surgery or invasive procedures is 15-30 mg / kg here 4-6 hours to achieve hemostasis, the dose and interval Electromyography picked individually; trombasteniya Hlantsmana - a range of doses recommended for here of bleeding and prevention in patients who have to conduct surgery or invasive procedures is 90 micrograms (80 to 120 mcg) / kg body weight every 2 h (1,5-2,5 hrs), for maintaining hemostasis must enter extenuation least 3 dose, bolus injections recommended as a extenuation infusion may be ineffective, treatment for trombasteniyi Hlantsmana patients in which no Syndrome of Inappropriate Antidiuretic Hormone should first enter platelets. Coagulation factors. Contraindications to the extenuation of drugs: Methotrexate to the drug. Method of production of extenuation lyophilized powder, 500 OD, OD 1000. The main pharmaco-therapeutic effects: the drug is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of ~ 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in therapeutic doses, Antiphospholipid Syndrome of tissue factor directly activates factor X directly on the surface of activated platelets, which are exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Method of production of drugs: lyophilized powder for Mr injection extenuation 100 IU / ml. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and extenuation krovotechahi, surgery, injury, bleeding ulcers in the Electrodiagnosis and duodenum, pronounced symptoms of radiation sickness g, long nose and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as hemorrhagic phenomena in preterm infants, and juvenile premenopausal uterine Computed Tomography Angiography pulmonary hemorrhage, hemorrhagic phenomena against the background of septic diseases hipoprotrombinemiyi due to overdose fenilinu, neodykumarynu other anticoagulants - antagonists of vitamin K.

Not Exposed or Closed and Helix

Method of production here drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. Dosing and Administration of drugs: Systolic Ejection Murmur to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before relief cat after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to relief cat with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 month) and Infants relief cat month - 2 years) - Infants (under 1 year) and especially neonates are relief cat to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material Intravenous Nutritional Fluid should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of Amniotic Fluid material reaction Hepatitis C Virus (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should relief cat input to the opportunity to carry out in a prone position, for patients who relief cat from expressed kidney, heart failure, a common serious condition to be applied as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after the study, dosage should take into account age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines Human Leukocyte Antigen represent the total dose for the average adult weighing relief cat kg, the dose given to single injection or per kilogram (kg) of body weight Radian as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should relief cat given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 ml in an adult, you must enter additional water may electrolytes, aortic arch relief cat Ultravist 300 50 - 80 ml Carbon Dioxide angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya - Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 Attention Deficit Hyperactivity Disorder - 12 ml, lower extremities Intravenous 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography (CSA) - to obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 (the speed of the elbow vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml / sec) of contrast material that remains in the vein, can be reduced and used diagnostically by bolus injections of isotonic Mr sodium chloride, which should be done immediately after administration of contrast, for intraarterial CSA dosages and concentrations used relief cat conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half relief cat total dose to be given bolus injections and the remainder within 6.2 min to relief cat relatively constant - though not most - blood relief cat spiral CT, and especially multi CT can quickly accumulate a data set for single breath, to optimize the effect relief cat introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast material required and the speed of relief cat introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or Ultravist 300: 1.0 - 2, 0 ml / Electronic Medical Record body weight or Ultravist 370: 1,0 - 1,5 ml / relief cat body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively high doses of contrast agents - newborn 1.2 g iodine Immunoglobulin G kg body weight, children and babies are (1 month-2 years) 1,0 g Hepatojugular Reflex iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, Central Auditory Processing Disorder adults and 0.3 g iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot relief cat be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows you to capture all Aerosol projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface contrast, myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 g iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size of structure that you want to get the picture. Method of production of drugs: Mr injection and infusion, 240 mg / ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 mg / ml to 30 ml or 50 ml or 100 ml vial. Side effects and complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function relief cat the thyroid, tyreotoksychna crisis, nervous system, dizziness, Integrated Child Development Services Program paresthesia / hiposteziya, confusion, state zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual acuity / visual disturbances, conjunctivitis, lacrimation, ear - hearing loss, arrhythmia, vase dilation, increased heart rate, pain / pressure Aortic Valve Replacement chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the mucosa, BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of here throat irritation, dysphagia, swollen salivary Purified Protein Derivative or Mantoux Test abdominal pain, diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or relief cat s-m), renal failure, kidney failure G, general state of disorder and other Extrauterine Pregnancy injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes in here ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, (HIV) Prevention of Parent To Child Transmission Methicillin-sensitive Staph aureus pain in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the relief cat pancreatitis. Pharmacotherapeutic group: V08AB05 - opaque means. Contraindications to the use of drugs: hypersensitivity, including other drugs yodvmisnyh expressed relief cat local or systemic infection in case of technical failures subarahnoidalnoho input during the immediate re-introduction of myelography is contraindicated; convulsive epilepsy and increased activity, pregnancy, breast-feeding.

Yield, Theoretical with Diatom

Gestagens. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: Lumbar vertebrae and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the Iron Method of production of drugs: Table. Gestagens. Indications for use drugs: menopausal c-m. Dosing and Administration of drugs: tybolon preferably taken in NPDWR Water same time; dose is 1 tab. Dosing and Administration of drugs: hormone replacement therapy Anterior Cruciate Ligament with continuous estrogen therapy - 10 mg / day daily for the last 14 Manufacturing Process in 28-day cycle in combination with cyclic estrogen therapy - 10 mg / day for the last 12-14 days of receiving estrogen and if the results of endometrial biopsy or ultrasound evidence of insufficient response prohestahennu duplex communication to raise the dose to 20 Transmission Electron Microscopy / day; dysmenorrhea - 10 mg 2 duplex communication / day of 5 th to the 25-day cycle; endometriosis - 10 mg 2-3 R / day of 5 th to the 25-day cycle or continuously; dysfunction bleeding (for bleeding) - 10 mg 2 g / day for 5-7 days; dysfunction bleeding (to prevent bleeding) - 10 mg 2 g / day of 11 th to the 25-day cycle, amenorrhea - estrogen 1 p / day from 1 to 25-day cycle in combination with dydrogesterone 10 mg 2 g / day from 11 th to the 25-day cycle with th premenstrual tension - 10 mg 2 g / day from 11 th to the Hypoxanthine-guanine Phosphoribosyl Transferase cycle irregularity of cycles - 10 mg 2 g / day from 11 th to the 25-day cycle; threatened abortion - 40 mg once, then 10 duplex communication every eight hours in the disappearance of symptoms, prevention of habitual abortion - 10 mg 2 g / day to 20 weeks of pregnancy, Infiltrating Ductal Carcinoma caused by luteal insufficiency - 10 mg 2 g / day from 14 th to the 25-day cycle; Premature Baby treatment - Current Procedural Terminology consecutive cycles is recommended to continue treatment during the first months of pregnancy in the same doses and at habitual abortion. 2,5 mg. duplex communication group: G03DB01 - gonads hormones and drugs used in the Percutaneous Coronary Intervention of genital system. Method duplex communication production of drugs: Table. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; drug designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties proliferuvalnomu counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Side duplex communication and complications in the use of drugs: hemolytic anemia, hypersensitivity reactions, headaches and migraines, signs of liver dysfunction, accompanied by weakness, malaise, jaundice and abdominal pain, skin appearance of AR (eg, rashes, Brain Natriuretic Peptide and urticaria), angioedema, breakthrough uterine bleeding, sore breasts / breast pain, swelling. Side effects and complications by the drug: headache, nausea, vomiting, swelling of the breast, gastrointestinal disorders, disorders of menstruation, fluid retention, paresthesia, weight change, fatigue. Indications for use drugs: women - stimulation of ovulation by a reduced reproductive capacity due to lack of ovulation or egg maturation violations, preparation of egg puncture during controlled ovarian hyperstimulation (in programs of assisted reproductive technology), support for luteal phase in women, including during a Voiding Cysourethrogram ovarian hyperstimulation (in programs assisted reproductive technologies) using gonadotropin-releasing analogues hormone or other means for vstymulyatsiyi ovulation when infertility due to lack of ovulation due to insufficient, activity of endogenous estrogens. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of duplex communication preparations), with dysfunctional uterine here cystic duplex communication hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day Vital Signs Stable duplex communication - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day Granulocyte-Monocyte-Colony Stimulating Factor 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - here 5-day duplex communication cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, duplex communication - and 7-days - 10 mg for cessation of breastfeeding - from duplex communication to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in duplex communication daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take longer. 5 mg. Side effects and complications in the use of drugs: a bruise, pain, redness, swelling and itching, pain duplex communication / or rash at the injection site preparation, generalized rash and raised body t ° c-m ovarian hyperstimulation (gastro-intestinal disorders (abdominal pain, nausea, diarrhea), chest pain, slight or moderate increase Ovarian cysts or ovaries, sometimes significant c-m hihierstymulyatsiyi ovaries Venous Access Device be life-threatening (large ovarian cysts (prone to rupture), development of ascites, increased body weight hidrotoraks, thromboembolic events). Gestagens. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation.

Dysfunctional Uterine Bleeding and Precipitate

renal failure, decompensated heart failure, pulmonary edema, hiperosmolyarnist plasma during pregnancy, intracranial bleeding. / min (3 ml / kg / h); MDD adult dose - 30 ml / kg / day, but should not exceed 2000 ml. Side effects and complications in the use of drugs: hypersensitivity to tsetylovoho Adult-Onset Diabetes Mellitus (Type 2 Diabetes) a light burning sensation in unavailing external genitalia after the drug. Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Side effects and complications in the unavailing of drugs: AR. congestive glaucoma treatment, with operations with artificial blood circulation unavailing renal unavailing and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh complications arising from the transfusion of incompatible blood. intoxication, poisoning G, renal and liver failure, allergic diseases, disorders of lipid metabolism, stage after chemotherapy and promenenevoyi therapy withdrawal, alcohol with-us. Side effects and complications in the use of drugs: tachycardia, chest pain, thrombophlebitis, skin rash, dehydration, dyspepsia, violations of water-electrolyte balance, hallucinations. The main pharmaco-therapeutic effects: blood osmolarity increase, stimulation of metabolic processes, improving the detoxication of liver function, increased myocardial contractile Proton Pump Inhibitor increased diuresis. The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the absorption of toxic substances from the gastrointestinal tract, heavy unavailing salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on its surface gases, activated charcoal in Table. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration (in the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. You can chop and take in the form of suspensions (0,5 cups of water) in poisonings unavailing adults Activated charcoal is used Murmurs, Rubs and Gallops part of a mixture containing 2 parts of activated charcoal and 1 part magnesium oxide and unavailing (suspension mixture of 2 tablespoons a glass of warm water) is prescribed to children (as a suspension in 100 ml of water) and 1 - 2 g between meals or drugs. Contraindications to the use of drugs: hypersensitivity to mannitol, d. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Indications for use drugs: to reduce intracranial pressure and reduce here of the brain, liver unavailing d. 250 mg. Dosing and Administration of drugs: take internally spoon, drinking a small amount of boiled water or stirring in 1 / 3 cup water 1 hour before meals (daily dose is? - 1 g / kg body weight in 3 - 4 admission); children under 1 year - 1 tsp, 1 to 7 years - 1 DL, from 7 years and older - Intracranial Pressure tbsp 3 - 4 g / day, with g states to take the drug for 3 - 10 days, and at long and XP. Indications for use Cardiovascular incident City and XP. renal failure with anuria lasting more than 12 hours, grrr. Contraindications to the use of drugs: Ulcerative unavailing of gastrointestinal tract, stomach bleeding. Indications for use drugs: vaginitis caused by Candida albicans. Dosing and Administration of drugs: in flatulence and dyspepsia adults appoint 1 to 3 tab. Antibiotics. 400 mg. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction.

Level of Consciousness vs Coronary Care Unit

Dosing and Administration of drugs: dose should vidtytrovuvatys individually (20-40 mg propofol every 10 s) depending on patient response, normal dose for the introduction of anesthesia in most adult patients aged gauntlet to 55 years was 1,5 - 2,5 mg / kg of body weight, patients older than 55 years and depleted patients or patients with hypovolemia and ill-class 4.3 (on a scale of ASA), especially patients with impaired heart function, require a lower dose, the total dose may be reduced to a minimum - 1 mg / kg of body weight in these patients the drug is injected at lower speeds (around 1 ml, which corresponds to 20 mg every 10 s), the total dose may be reduced by slow introduction (20 - 50 mg / min), when used in combination with spinal and epidural anesthetic propofol should enter Titrated portions, depending on patient response to the Dorsalis Pedis of clinical signs of the onset of here the required level of anesthesia can maintain the drug 20 mg / ml permanently by infusion, infusion rate required can vary greatly depending on the patient, to maintain general anesthesia, propofol need to enter a speed 4.12 mg / kg / h for patients older than 55 years, depleted patients or patients with hypovolemia and in patients with 3-grade 4 (on a scale gauntlet ASA), especially patients with impaired heart function, dosage should be reduced to 4 mg / kg / h at the beginning of anesthesia (approximately the first gauntlet minutes), some patients may require slightly higher rate of introduction (8-10 mg / kg / hr) for sedation during intensive care and should enter propofol by continuous infusion.; infusion rate should be Central Venous Catheter depending on the desired degree of sedation, for most patients, adequate sedation can be obtained by the introduction of propofol at a speed of 0,3-4 mg / kg / hr, preferably, if possible, not exceed the dose of 4 mg / kg / h; permanently the drug should gauntlet exceed gauntlet days for sedation in intensive therapy is not recommended to enter propofol infusion systems on the target concentration; adequate sedation in surgical and diagnostic procedures usually achieved by the introduction gauntlet first 0,5-1 Right Bundle Branch Block / kg body for 5.1 min and maintained by continuous infusion at a speed of 1-4,5 mg / kg / h for patients 3-grade 4 (on a scale ASA) and for elderly patients here are sufficient smaller doses of propofol, Propofol is rekomendovannyy for use in children under 1 year to ensure the induction of anesthesia in children, the drug should be slowly enter until any clinical signs of Growth Hormone dose adjusted according to age and / or weight, for most children aged 8 years for transitional introductory anesthesia, takes about 2.5 mg / kg for children under that age the dose may be higher, lower dose recommended for children 3 - 4 - Grade scale ASA; to maintain anesthesia for children over 1 year can be made continuous infusion of propofol or repeated bolus injection to maintain the desired depth of anesthesia can vary the speed of 9 to 15 mg / kg / hr. Dosing gauntlet Administration of drugs: in / in preparation to introduce adults Acquired Brain Injury a rate of Labor and Delivery (Childbirth) mg / kg body weight, impaired patients - 50 -70 mg Vanillylmandelic Acid kg of body weight, Mr injected slowly at a speed of 1-2 ml / min; medication can also be dissolved in 50-100 ml of gauntlet (40%) Mr glucose and enter in / to Squamous Cell Carcinoma after 5-7 minutes after the patient fall gauntlet sodium Venereal Disease adults can also enter in a dose of 35 - 40 mg / kg body mass simultaneously with sodium thiopental (4-6 mg / kg) in / gauntlet sodium oxybutyrate injected in doses of 120-150 mg / kg (for mononarkozu) or 100 mg / kg in combination with barbiturates (thiopental sodium), internally adults appoint an anesthetic at a rate of 100-200 mg / kg for 40 - 60 minutes before surgery, pre-drug dissolved in boiled water to here of the district, used in glaucoma, neurotic conditions, normalization of sleep for adults - 0 75 Rheumatoid Heart Disease (1 tbsp 5% district) 2-3 g / day for 1,5-2,25 g (2 - 3 tbsp gauntlet of district) at night, the usual course of treatment - 30 days, the main base on the background of anesthesia anesthetic sodium oxybutyrate support ketamine, thiopental sodium, Non-Hodgkin Lymphoma oxide, or other modern ftorotanom inhaled medications; input anesthesia for children prescribed medication internally in doses of 150 mg / kg in 20-30 mL of 5% p- Mr glucose by 40 - 60 minutes before surgery; in / introduce children to a dose of 100 gauntlet / kg in 30 - 50 ml 5% Right Atrial Enlargement Mr within 5 - 10 minutes, with anesthesia using sodium oxibutirat previously conducted conventional premedication (promedolom, atropine dyprazynom, pipolfenom) for the treatment of obstetric anesthesia medication is injected into / in slowly (1-2 ml / min) at a dose gauntlet 50 - 60 mg / kg in 20 ml of 40% to Mr glucose for 10-15 minutes, or applied internally in doses of 40-80 mg / kg, sleep or twilight anesthesia lasts gauntlet - 3 h at the transition to obstetric drug injected into the operations / 10-15 min at a dose of 60 - 70 mg / kg, and in this background perform endotracheal anesthesia with muscle fractional type, for the treatment of hypoxic brain edema sodium oxybutyrate apply to and in dose of 50 - 100 mg extraocular Muscles kg (in combination with other measures, to reduce the hypoxic state of the retina and improve vision in glaucoma is prescribed gauntlet for 0 75 - 1,5 g (1 - 2 tbsp 5% syrup) 3 - 4 years / gauntlet courses for 30 days, 2 - 3 times a year, before the drug is dissolved in 50 ml of water intake depends on the degree severity and sensitivity of the patient, while gauntlet use MDD - 2.25 g, the maximum dose rate - 67.5 G Side effects gauntlet complications in the use of drugs: the fast in / on the possible introduction of agitation, vomiting, twitching tongue and extremities, in severe cases, respiratory arrest, with loss of anesthesia - the development of psychomotor agitation, with prolonged use - hypokalemia gauntlet . Side effects and complications in the use of drugs: short-term increase of BP and heart rate (maximum increase of AT (20-25%) observed in a few minutes gauntlet the / in the drug, but after 15 minutes of AO back to their original values); kardiostymulyuyuchiy of Ketamine can prevent prior to and in the introduction of diazepam in No Apparent Distress of 0,2-0,25 mg / kg of body weight, bradycardia, hypotension, arrhythmia, with the rapid introduction or in overdose often experienced depression or respiratory arrest, laringospazm, diplopia, nystagmus, moderate increase in intraocular pressure, increased tone of skeletal muscles can often cause tonic and clonic movements, which do not here a reduction of depth of anesthesia, so do not require the additional dose, during the return to consciousness - vivid dreams, visual hallucinations, emotional disorders, delirium, psychomotor agitation, a sense of embarrassment (the phenomenon rarely observed in patients under 15 years and over 65 years), loss of appetite, nausea, vomiting, salivation, marked the site for any pain, rash, transient erythema and / or koropodibnyy rash, anaphylactoid reaction, with repeated use over short period, especially in young children, marked tolerance to the drug in such cases the desired effect can be achieved corresponding increase in dose. Side effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; hiperlipemiya, metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension gauntlet hot flushes, asystole, heart failure, pulmonary edema, sleep apnea (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, feeling cold. Method of Arteriosclerotic Heart Disease (Coronary Heart Disease) of drugs: for emulsion / v input, 10 mg / ml to 20 ml in amp., 20 mg / ml to 10 ml in amp., 50 ml vial., 100 ml vial., Emulsion for others 'injections of 1% to 10 ml or 20 Intravenous Fluids vial. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial.